Amgen, Horizon accuse FTC of trying to dodge constitutionality challenge
Shutterstock/sockagphoto
The Federal Trade Commission is attempting to prevent an Illinois federal court from hearing arguments that its administrative proceedings violate the Constitution, Amgen and Horizon Therapeutics have said.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10